The inter-group comparisons also showed that T2DM patients, irrespective of metformin use, had significantly different levels of plasma GCA, TCDCA, CA, HDCA, GDCA, CDCA, DCA and TCA. The gene discussed is GNAT3; the disease is type 2 diabetes mellitus.